Home > Compound List > Product Information
(3S,5S)-Atorvastatin Sodium Salt_Molecular_structure_CAS_501121-34-2)
Click picture or here to close

(3S,5S)-Atorvastatin Sodium Salt

Catalog No. A791735 Name Toronto Research Chemicals
CAS Number 501121-34-2 Website http://www.trc-canada.com
M. F. C33H34FN2NaO5 Telephone +1 (416) 665-9696
M. W. 580.6216332 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage -20°C Freezer Chembase ID: 160865

SYNONYMS

IUPAC name
sodium (3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate
IUPAC Traditional name
sodium (3S,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxyheptanoate
Synonyms
(βS,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Sodium
3S,5S-Atorvastatin Sodium

DATABASE IDS

CAS Number 501121-34-2

PROPERTIES

Certificate of Analysis Download
Apperance White Solid
Melting Point 182-184°C
Solubility Chloroform
Solubility DMSO
MSDS Link Download
Storage Condition -20°C Freezer

DETAILS

Description (English)
A selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.

REFERENCES

  • Kearney, A.S., et al.: Pharm. Res., 10, 1461 (1993)
  • Heinonen, T.M., et al.: Clin. Ther., 18. 853 (1993)
  • Whitfield, L.R., et al.: Eur. J. Drug Metab. Pharmacokinet., 25, 97 (2000)